Video

View G. Steven Burrill's Presentation from BioConference Live
November 17, 2009.

View video 

Podcast

Jerry Flanagan, healthcare policy director for ConsumerWatchdog, discusses his group’s lawsuit against Anthem Blue Cross of California over its rate hikes, what they mean for healthcare reform, and why the proposed healthcare legislation wouldn’t have prevented Anthem from instituting the rate increases in the first place.
Hear the podcast 

G. Steven Burrill

Welcome from the CEO

Flash required to view this video. Download the latest version here

 G. Steven Burrill 
 
Sign up for a free subscription to The Burrill Weekly Brief 
Sign up to receive email notifications about our upcoming events and news.



James D. Watson

Managing Director

Mr. Watson has broad therapeutic and drug discovery experience in strategy and partnership formation. Prior to joining Burrill & Company, he was a Senior VP with Incyte Genomics heading the Business Development and Marketing organizations. Before Incyte, he was General Manager and previously VP Business Development for Chemdex, a pioneering marketplace for research scientists with over 100 employees. Prior to Chemdex, Mr. Watson was Head of the San Francisco office of The Wilkerson Group where he built the office from 4 to over 30 consultants. Earlier, he gained operational experience with Lilly in Indianapolis and the UK in a variety of new product development and commercially focused roles. Mr. Watson received a Fulbright Scholarship and MBA from Indiana University and lectured in Economics at Portsmouth University, England.